Dr. Fernando Cabanillas Escalona

Professor

Contact Info

  • School of Medicine
    Internal Medicine Department
    Hematology & Oncology Section
    P.O. Box 365067
    San Juan, PR 00936-5067
  • 787-754-0101, Ext. 5051

Education

  • Degree: M.D. University of Puerto Rico School of Medicine, San Juan, Puerto Rico – 1966-1970
  • Degree: BS University of Puerto Rico (biology major) Río Piedras, PR. – 1963-1966

INTERNSHIP & RESIDENCY:

  • University District Hospital, Puerto Rico, Internal Medicine – July 1970 – June 1973-

FELLOWSHIP:

  • University District Hospital, Puerto Rico, Hematology – July 1973 – June 1974
  • The University of Texas System Cancer Center, M. D. Anderson Hospital, Department of
  • Developmental Therapeutics, Two-Year Fellowship in Medical Oncology – July 1974 – June 1976

ACADEMIC POSITIONS

Primary Appointment: Chairman, Centro de Cancer Auxilio Mutuo Hospital Español Auxilio Mutuo de Puerto Rico –

Professor of Medicine: University of Puerto Rico, School of Medicine

Adjunct Professor of Medicine: The University of Texas, M. D. Anderson Cancer Center

Adjunct Professor of Medicine, Moffitt Cancer Center, Tampa, Florida

Faculty Associate, Department of Developmental Therapeutics, M. D. Anderson Hospital – July 1976 – June 1977

Assistant Internist and Assistant Professor of Medicine, Department of Developmental Therapeutics, M. D. Anderson Hospital – 1977 –1978

Associate Internist and Assistant Professor of Medicine, Department of Developmental Therapeutics, M.D. Anderson Hospital – 1978 –1980

Associate Internist and Associate Professor of Medicine, Department of Developmental Therapeutics, M. D. Anderson Hospital 1980 –1983

Internist and Associate Professor of Medicine, Department of Hematology, M. D. Anderson Hospital -1983-1986

Internist and Professor of Medicine, Department of Lymphoma/Myeloma, M. D., Anderson Hospital 1986-2002

Adjunct Professor of Medicine, MD Anderson Hospital
Medical Director Auxilio Mutuo Cancer Center – 2002-2018

February 2009 – to present Professor of Medicine, UPR School of Medicine

August 2009   – to present Adjunct Professor of Medicine, Moffitt Cancer Center

ACADEMIC ADMINISTRATIVE APPOINTMENTS:

Chief, Lymphoma/Myeloma Section, MD Anderson – 1984-1997

Chairman, Department of Lymphoma/Myeloma, MD Anderson 1998- 2002

Chairman, Centro de Cancer Auxilio Mutuo, Hospital Español Auxilio Mutuo de Puerto Rico 2002-present

RESEARCH INTEREST

RESEARCH: GRANT & CONTRACTS:

Schering Corp. Fund for Research in Hodgkin’s Disease.

University Cancer Foundation- “Monitoring Therapy of Low Grade Lymphoma by PCR”  (1/5/93-1/4/94).

E.I. Dupont- “A Phase II Clinical Trial to Evaluate the Safety and

Efficacy of a Single Weekly Schedule of Administration of Brequinar Sodium (DuP 785) in Cancer Patients with Refractory Lymphoma or Chronic Lymphocytic Leukemia” (DM89-057).

NCI – Co-Investigator, “Role of Human Retroviruses in Human AIDSRelated Lymphomas” (CA52778; R. Ford-P.I.; 7/1/90 – 6/30/93).

Adria Laboratories- “Idarubicin Study” (DM91-004/DM90-115/DM91033; 1/1/92-2/28/94).

IDEC Pharmaceuticals Corp.- “A Phase II Study of Anti-Idiotype Antibody for the Treatment of Recurrent B-Cell Lymphomas” (DM91054; 8/1/91-1/31/95).

NCI – Co-Investigator, “Minimal Residual Disease in Lymphomas With the t(14;18)”  (RO1  CA49443-03; M.S. Lee-P.I.; 4/1/89 – 3/31/94).

Berlex Laboratories- “Intensive vs. Milder Therapy for Stage IV Low

Grade Follicular Lymphomas Monitored by Polymerase Chain Reaction Technique” (DM92-103; 2/5/94-2/4/95)

NCI Interactive RO1 (total award for 4 years= $2,328,226.) Coordinator, “Monitoring Therapy of Low Grade Lymphoma by PCR” (RO1 CA62518; F. Cabanillas-P.I.-Project 1; 9/1/93 – 6/30/98)

Schering Corp.- “STUDIES WITH GM-CSF” (DM92-053/DM92-054; 9/1/94 – 2/28/95)

Bristol-Myers Squibb Company- “Phase I Taxol” (DM93-098; 9/12/94 – 8/31/95)